Phase 2 Readout~quarter

Phase 2 Readout: inbrx-106

Indication
first-line HNSCC

Other upcoming events for INBX

PDUFA DatePDUFA Date: ozekibart
Phase 3 ReadoutPhase 3 Topline: A Phase 2/3, Randomized Study of INBRX-106 Combined With Pembrolizumab Versus Pembrolizumab as First

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar